Jason Randolph Andrews

Jason Randolph Andrews

Auto-generated profile, based on publicly available information

Jason Randolph Andrews

Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in The Lancet
Verified
Journal Article
Closed access
NGNeel R Gandhi
Neel R Gandhi
AMAnthony Moll
Anthony Moll
ASA Willem Sturm
A Willem Sturm
RPRobert Pawinski
Robert Pawinski
TGThiloshini Govender
Thiloshini Govender
GFGerald Friedland
Gerald Friedland

19 June 2012 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
SBSanjay Basu
Sanjay Basu
JAJason Andrews
Jason Andrews
SKSandeep Kishore
Sandeep Kishore
RPRajesh Panjabi
Rajesh Panjabi
DSDavid Stuckler
David Stuckler
Private sector healthcare delivery in low- and middle-income countries is sometimes argued to be more efficient, accountable, and sustainable than public sector delivery. Conversely, the public sector is often regarded as providing more equitable and evidence-based care. We performed a systematic review of research studies investigating the performance of private and public sector delivery in low- and middle-income countries. Peer-reviewed studies including case studies, meta-analyses, reviews, and case-control analyses, as well as reports published by non-governmental organizations and international agencies, were systematically collected through large database searches, filtered through methodological inclusion criteria, and organized into six World Health Organization health system themes: accessibility and responsiveness; quality; outcomes; accountability, transparency, and regulation; fairness and equity; and efficiency. Of 1,178 potentially relevant unique citations, data were obtained from 102 articles describing studies conducted in low- and middle-income countries. Comparative cohort and cross-sectional studies suggested that providers in the private sector more frequently violated medical standards of practice and had poorer patient outcomes, but had greater reported timeliness and hospitality to patients. Reported efficiency tended to be lower in the private than in the public sector, resulting in part from perverse incentives for unnecessary testing and treatment. Public sector services experienced more limited availability of equipment, medications, and trained healthcare workers. When the definition of “private sector” included unlicensed and uncertified providers such as drug shop owners, most patients appeared to access care in the private sector; however, when unlicensed healthcare providers were excluded from the analysis, the majority of people accessed public sector care. “Competitive dynamics” for funding appeared between the two sectors, such that public funds and personnel were redirected to private sector development, followed by reductions in public sector service budgets and staff. Studies evaluated in this systematic review do not support the claim that the private sector is usually more efficient, accountable, or medically effective than the public sector; however, the public sector appears frequently to lack timeliness and hospitality towards patients. Please see later in the article for the Editors' Summary

1 March 2009 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
EOEvan W. Orenstein
Evan W. Orenstein
SBSanjay Basu
Sanjay Basu
NSN Sarita Shah
N Sarita Shah
JAJason R Andrews
Jason R Andrews
GFGerald H Friedland
Gerald H Friedland
AGAlison P Galvani
Alison P Galvani

13 April 2022 in Med
Verified
Journal Article
Closed access
ANAravind Natarajan
Aravind Natarajan
SZSoumaya Zlitni
Soumaya Zlitni
EBErin F. Brooks
Erin F. Brooks
SVSummer E. Vance
Summer E. Vance
ADAlex Dahlen
Alex Dahlen
ABAmi S. Bhatt
Ami S. Bhatt

19 January 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JAJason R. Andrews
Jason R. Andrews
FNFarzad Noubary
Farzad Noubary
RWRochelle P. Walensky
Rochelle P. Walensky
RCRodrigo Cerda
Rodrigo Cerda
ELElena Losina
Elena Losina
CJCharles Robert Horsburgh, Jr
Charles Robert Horsburgh, Jr
(See the Editorial Commentary by Vernon and Villarino, on pages 792–3 .) Background. The risk of progression to active tuberculosis is greatest in the several years following initial infection. The extent to which latent tuberculosis infection reduces the risk of progressive disease following reexposure and reinfection is not known. Indirect estimates from population models have been highly variable. Methods. We reviewed prospective cohort studies of persons exposed to individuals with infectious tuberculosis that were published prior to the widespread treatment of latent tuberculosis to estimate the incidence of tuberculosis among individuals with latent tuberculosis infection (LTBI group) and without latent tuberculosis (uninfected; UI group). We calculated the incidence rate ratio (IRR) of tuberculosis disease following infection between these 2 groups. We then adjusted incidence for expected reactivation, proportion of each group that was infected, and median time of observation following infection during the study. Results. We identified 18 publications reporting tuberculosis incidence among 23 paired cohorts of individuals with and without latent infection (total N = 19 886). The weighted mean adjusted incidence rate of tuberculosis in the LTBI and UI groups attributable to reinfection was 13.5 per 1000 person-years (95% confidence interval [CI]: 5.0–26.2 per 1000 person-years) and that attributable to primary infection was 60.1 per 1000 person-years (95% CI: 38.6–87.4 per 1000 person-years). The adjusted IRR for tuberculosis in the LTBI group compared with the UI group was 0.21 (95% CI: .14–.30). Conclusions. Individuals with latent tuberculosis had 79% lower risk of progressive tuberculosis after reinfection than uninfected individuals. The risk reduction estimated in this study is greater than most previous estimates made through population models.

1 January 2012 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
RCRumi Chunara
Rumi Chunara
JAJason R. Andrews
Jason R. Andrews
JBJohn S. Brownstein
John S. Brownstein
During infectious disease outbreaks, data collected through health institutions and official reporting structures may not be available for weeks, hindering early epidemiologic assessment. By contrast, data from informal media are typically available in near real-time and could provide earlier estimates of epidemic dynamics. We assessed correlation of volume of cholera-related HealthMap news media reports, Twitter postings, and government cholera cases reported in the first 100 days of the 2010 Haitian cholera outbreak. Trends in volume of informal sources significantly correlated in time with official case data and was available up to 2 weeks earlier. Estimates of the reproductive number ranged from 1.54 to 6.89 (informal sources) and 1.27 to 3.72 (official sources) during the initial outbreak growth period, and 1.04 to 1.51 (informal) and 1.06 to 1.73 (official) when Hurricane Tomas afflicted Haiti. Informal data can be used complementarily with official data in an outbreak setting to get timely estimates of disease dynamics.